Register for our free email digests:
Latest From Chongqing Fochon Pharmaceutical Research Co. Ltd.
Biopharma financing totaled $6.4 billion, a 39% increase over Q3. Twenty-three M&As were completed with a combined potential value of $19.8 billion, and there were 103 biopharma alliances totaling $2.5 billion in potential pre-commercialization value, down 25% from the previous quarter.
- Therapeutic Areas
- Pacific Rim
- Parent & Subsidiaries
- Seikagaku Corp.
- Senior Management
- Ken Mizutani, Pres.
- Contact Info
Phone: (81) 3-5220-8950
6-1 Marunouchi 1-chome
Tokyo , 103
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.